An overview on Anti-Vegf and in search for an ideal anti VEGF agent

نویسندگان

چکیده

An overview on Anti-Vegf and in search for an ideal anti VEGF agent - IJCEO- Print ISSN No: 2395-1443 Online No:- 2395-1451 Article DOI 10.18231/j.ijceo.2022.092, Indian Journal of Clinical Experimental Ophthalmology-Indian J Clin Exp Ophthalmol

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Anti-VEGF and Beyond

Department of Ophthalmology, University Medical Center Göttingen, Göttingen, Germany Artemis Eye Clinic, Dillenburg, Germany Internationale Innovative Augenchirurgie, Duesseldorf, Germany International Vision Correction Research Centre Network (IVCRC.net), Department of Ophthalmology, University of Heidelberg and Eyeclinics Ahaus-Raesfeld-Rheine, Dr. Gerl & Colleagues, Ahaus Lag, Germany Depart...

متن کامل

development and implementation of an optimized control strategy for induction machine in an electric vehicle

in the area of automotive engineering there is a tendency to more electrification of power train. in this work control of an induction machine for the application of electric vehicle is investigated. through the changing operating point of the machine, adapting the rotor magnetization current seems to be useful to increase the machines efficiency. in the literature there are many approaches wh...

15 صفحه اول

The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents.

Multiple cellular pathways influence the growth and metastatic potential of tumors. This creates heterogeneity, redundancy, and the potential for tumors to bypass signaling pathway blockade, resulting in primary or acquired resistance. Combining therapies that inhibit different signaling pathways has the potential to be more effective than inhibition of a single pathway and to overcome tumor re...

متن کامل

Pazopanib and anti-VEGF therapy

Pazopanib (Votrient™, GlaxoSmithKline), a multi-kinase inhibitor with activity against VEGFR and other receptors, was recently approved by the FDA for the treatment of advanced renal cell carcinoma (RCC). Here, we review the history of its development, together with an overview of VEGF and its receptors and co-receptors. Results from selected clinical trial data in RCC and other malignant disea...

متن کامل

Screening and improvement of an anti-VEGF DNA aptamer.

To obtain an aptamer with a high affinity for vascular endothelial growth factor (VEGF), we focused on the receptor-binding domain (RBD) of VEGF as a target epitope. Three rounds of screening gave Vap7, which bound to the VEGF isoforms VEGF(121) and VEGF(165) with K(D) values of 1.0 nM and 20 nM, respectively. Moreover, Vap7 showed specificity within the VEGF family. Secondary structure predict...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Indian Journal of Clinical and Experimental Ophthalmology

سال: 2022

ISSN: ['2395-1443', '2395-1451']

DOI: https://doi.org/10.18231/j.ijceo.2022.092